News + Filings Transactions
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
|
ALTSHULER DAVID
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
08/11/2023 |
4
| ALTSHULER DAVID (EVP, Global Research and CSO) has filed a Form 4 on VERTEX PHARMACEUTICALS INC / MA
Txns:
| Sold 63 shares
@ $345.51, valued at
$21.8k
|
|
02/28/2023 |
4
| ALTSHULER DAVID (EVP, Global Research and CSO) has filed a Form 4 on VERTEX PHARMACEUTICALS INC / MA
Txns:
| Paid exercise price by delivering 3,970 shares
@ $289.12, valued at
$1.1M
Sold 3,636 shares
@ $287.23, valued at
$1M
Sold 300 shares
@ $288.74, valued at
$86.6k
Sold 302 shares
@ $289.6, valued at
$87.5k
|
|
02/22/2023 |
4
| ALTSHULER DAVID (EVP, Global Research and CSO) has filed a Form 4 on VERTEX PHARMACEUTICALS INC / MA
Txns:
| Paid exercise price by delivering 3,750 shares
@ $292.85, valued at
$1.1M
Sold 36 shares
@ $291.01, valued at
$10.5k
Sold 1,223 shares
@ $292.76, valued at
$358k
Sold 1,843 shares
@ $294.03, valued at
$541.9k
Sold 900 shares
@ $294.73, valued at
$265.3k
|
|
02/14/2023 |
4
| ALTSHULER DAVID (EVP, Global Research and CSO) has filed a Form 4 on VERTEX PHARMACEUTICALS INC / MA
Txns:
| Paid exercise price by delivering 3,461 shares
@ $294.33, valued at
$1M
Paid exercise price by delivering 5,990 shares
@ $298.26, valued at
$1.8M
Sold 245 shares
@ $296.44, valued at
$72.6k
Sold 2,160 shares
@ $298.47, valued at
$644.7k
Sold 1,893 shares
@ $299.36, valued at
$566.7k
Sold 500 shares
@ $300.23, valued at
$150.1k
|
|
02/08/2023 |
4
| ALTSHULER DAVID (EVP, Global Research and CSO) has filed a Form 4 on VERTEX PHARMACEUTICALS INC / MA
Txns:
| Sold 12 shares
@ $300.39, valued at
$3.6k
Sold 70 shares
@ $302, valued at
$21.1k
Sold 100 shares
@ $303.64, valued at
$30.4k
Sold 349 shares
@ $305.08, valued at
$106.5k
Sold 620 shares
@ $306.7, valued at
$190.2k
Sold 153 shares
@ $309.06, valued at
$47.3k
Exercised 1,304 options to buy
@ $187.53, valued at
$244.5k
|
|
02/03/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
11/17/2022 |
4
| ALTSHULER DAVID (EVP, Global Research and CSO) has filed a Form 4 on VERTEX PHARMACEUTICALS INC / MA
Txns:
| Sold 34 shares
@ $308.61, valued at
$10.5k
|
|
11/09/2022 |
4
| ALTSHULER DAVID (EVP, Global Research and CSO) has filed a Form 4 on VERTEX PHARMACEUTICALS INC / MA
Txns:
| Sold 140 shares
@ $299.72, valued at
$42k
Sold 210 shares
@ $300.96, valued at
$63.2k
Sold 189 shares
@ $301.99, valued at
$57.1k
Sold 261 shares
@ $303.21, valued at
$79.1k
Sold 280 shares
@ $304.58, valued at
$85.3k
Sold 140 shares
@ $305.39, valued at
$42.8k
Sold 83 shares
@ $306.57, valued at
$25.4k
Exercised 1,303 options to buy
@ $187.53, valued at
$244.4k
|
|
08/10/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
07/21/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/28/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/22/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/16/2022 |
4
| ALTSHULER DAVID (EVP, Global Research and CSO) has filed a Form 4 on VERTEX PHARMACEUTICALS INC / MA
Txns:
| Sold 2,444 shares
@ $232.02, valued at
$567.1k
|
|
02/14/2022 |
4
| ALTSHULER DAVID (EVP, Global Research and CSO) has filed a Form 4 on VERTEX PHARMACEUTICALS INC / MA
Txns:
| Paid exercise price by delivering 3,518 shares
@ $237.74, valued at
$836.4k
Sold 841 shares
@ $233.92, valued at
$196.7k
Sold 757 shares
@ $234.95, valued at
$177.9k
Sold 601 shares
@ $236.28, valued at
$142k
Sold 98 shares
@ $237.23, valued at
$23.2k
|
|
11/16/2021 |
4
| ALTSHULER DAVID (EVP, Global Research and CSO) has filed a Form 4 on VERTEX PHARMACEUTICALS INC / MA
Txns:
| Sold 14 shares
@ $186.8, valued at
$2.6k
Sold 20 shares
@ $187.51, valued at
$3.8k
|
|
05/19/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/26/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/19/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/16/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/12/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/05/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
11/18/2020 |
4
| ALTSHULER DAVID (EVP, Global Research and CSO) has filed a Form 4 on VERTEX PHARMACEUTICALS INC / MA
Txns:
| Sold 10 shares
@ $222.45, valued at
$2.2k
Sold 18 shares
@ $223.57, valued at
$4k
Sold 10 shares
@ $224.32, valued at
$2.2k
|
|
08/10/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
08/05/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
05/19/2020 |
4
| ALTSHULER DAVID (EVP, Global Research and CSO) has filed a Form 4 on VERTEX PHARMACEUTICALS INC / MA
Txns:
| Sold 2 shares
@ $274.98, valued at
$550 Sold 4 shares
@ $276.44, valued at
$1.1k
Sold 5 shares
@ $279.48, valued at
$1.4k
Sold 9 shares
@ $280.47, valued at
$2.5k
Sold 4 shares
@ $281.55, valued at
$1.1k
Sold 6 shares
@ $282.77, valued at
$1.7k
Sold 3 shares
@ $283.74, valued at
$851.2 Sold 5 shares
@ $284.98, valued at
$1.4k
Sold 10 shares
@ $286.12, valued at
$2.9k
Sold 15 shares
@ $287.19, valued at
$4.3k
Sold 19 shares
@ $288.05, valued at
$5.5k
|
|
05/14/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
05/08/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
05/06/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/26/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/19/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/12/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/07/2020 |
4
| ALTSHULER DAVID (EVP, Global Research and CSO) has filed a Form 4 on VERTEX PHARMACEUTICALS INC / MA
Txns:
| Granted 18,204 shares
@ $0 Granted 8,166 shares
@ $0 Granted 12,387 shares
@ $0 Sold 1,462 shares
@ $238.74, valued at
$349k
Sold 630 shares
@ $239.63, valued at
$151k
Sold 280 shares
@ $240.82, valued at
$67.4k
Sold 154 shares
@ $242.47, valued at
$37.3k
Exercised 1,303 options to buy
@ $187.53, valued at
$244.4k
Exercised 1,223 options to buy
@ $155.57, valued at
$190.3k
|
|
02/05/2020 |
4
| ALTSHULER DAVID (EVP, Global Research and CSO) has filed a Form 4 on VERTEX PHARMACEUTICALS INC / MA
Txns:
| Sold 749 shares
@ $229.35, valued at
$171.8k
Sold 785 shares
@ $230.6, valued at
$181k
Sold 2,122 shares
@ $231.67, valued at
$491.6k
Sold 470 shares
@ $232.88, valued at
$109.5k
Exercised 1,796 options to buy
@ $91.05, valued at
$163.5k
Exercised 2,330 options to buy
@ $86.52, valued at
$201.6k
|
|
11/26/2019 |
4
| ALTSHULER DAVID (EVP, Global Research and CSO) has filed a Form 4 on VERTEX PHARMACEUTICALS INC / MA
Txns:
| Exercised 3,910 shares
@ $187.53, valued at
$733.2k
Sold 3,910 shares
@ $219.37, valued at
$857.7k
Exercised 3,910 options to buy
@ $187.53, valued at
$733.2k
|
|
|
|
|